Polymeric Biomaterials Market is expected to growing at a CAGR of Around 16% by 2026 | BASF, Osteotech, Medtronic, Biomet, Stryker Corporation

The Global Polymeric Biomaterials Market Research Report Forecast 2020-2026: The Polymeric Biomaterials Market report is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand, and supply data (as applicable). The report explores the current outlook in global and key regions from the perspective of players, countries, product types, and end industries. The report provides an in-depth analysis of parent market trends, macro-economic indicators, and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

The global polymeric biomaterials market is expected to grow with a CAGR of Around 16% by 2025

The Prominent Key Players of Polymeric Biomaterials Market: BASF, Bezwada Biomedical, Corbion, Zimmer Biomet, Royal, Koninklijke, Covestro, Evonik Industries, Starch Medical, Victrex, W. L. Gore and Associate, Bayer, DSM Biomedical, Purac Biomaterials, Ticona, Invibo, Covalon Technologies, Osteotech, Medtronic, Biomet, Stryker Corporation

Get Sample PDF Copy of Latest Research on Polymeric Biomaterials Market 2020
https://www.marketinsightsreports.com/reports/01141750879/global-polymeric-biomaterials-market-research-report-2020/inquiry?Mode=31&Source=op

Scope of the Report
Polymeric biomaterials refer to the synthetic, natural, and hybrid materials that are applied in the field of therapeutics and pharmaceuticals. The similarities between natural tissues, proteins, and polysaccharides and synthetic polymers with their long-chain architecture lead to the reasonable conclusion that synthetic polymers are better representations of natural tissue response, when compared to metals and ceramics.

Industry News:

BASF and SIBUR collaborate to develop innovative polymer solutions

Moscow, Russia, and Ludwigshafen, Germany, June 18, 2019: SIBUR and BASF are collaborating to develop innovative polymer solutions at SIBUR's PolyLab Research and Development Center located in Moscow, Russia. The signing ceremony of the Memorandum of Cooperation took place on May 30, 2019 at SIBUR's newly inaugurated state-of-the-art PolyLab at the Skolkovo Innovation Center to seal the strong commitment from SIBUR and BASF.
Both companies will work together to leverage on the digital technologies in production and R&D, and to develop an innovative range of polymers using the plastic additives offered by BASF. In addition, BASF will support with its technical expertise the development of new technology tests at PolyLab, the main R&D hub of SIBUR NIOST, and SIBUR's production facilities.

Evonik launches world's first commercial line of bioresorbable PLA-PEG copolymers for implantable medical devices

October 21, 2019: Evonik, a global leader in biomaterials, today announced the commercial launch of the world's first bioresorbable portfolio of PLA-PEG copolymers for use in implantable medical device applications. The innovative portfolio expands Evonik's ability to help medical device customers enhance the safety, biocompatibility and performance of their implantable products, and further strengthens the Company's growth engine Health & Care. RESOMER PLA-PEG copolymers combine the hydrophobic (water repelling) properties of polylactide (PLA) polymers with the hydrophilic (water attractant) properties of polyethylene glycol (PEG). As triblock copolymers, the portfolio can replicate the mechanical strength of standard RESOMER polymers but enables degradation rates up to six times faster.
Key Market Trends

Cardiology is Expected to Hold its Highest Market Share in the Application Segment

In the application segment of the market, cardiology is believed to have the largest market size and is expected to witness a CAGR of 16.0% during the forecast period.

Recent years have observed promising applications of polymeric biomaterials in cardiac repair and regeneration. Organ failure is also one of the major health problems, globally recognized. As per the World Health Organization (WHO), it is estimated that there will be 23.6 million deaths annually by 2030, due to CVD, with the largest increase in Southeast Asia. To combat the rising burden of diseases and related unmet needs, several cardiac specialized universities across the world have launched initiatives in cardiac restoration therapy, to act as alternative therapeutic options to replace transplants. However, the growth is expected to be steady, as market approval is a major hindrance. Over the forecast period, the growth is estimated to be about 16.0%.

North America Dominates the Market and is Expected to Remain the Same in the Forecast Period

North America currently dominates the market for polymeric biomaterials and is expected to continue its stronghold for a few more years. In the United States, there are several private companies that have vast expertise in biopolymers with access to advanced technology and custom synthesis. These companies have businesses across drug research and medical device manufacturers, which act as contract research organizations acting as partners to major healthcare firms. Furthermore, the region has manufacturing units for several major medical device and pharmaceutical companies, such as Abbott, Allergan, 3M, and Baxter, among others, which have a wide range of products, across multiple therapeutic areas, which drives the investment opportunity by investors, high competition for raw material providers, and long-term partnerships for the development of advanced end products to be used in hospitals. Thus, over the forecast period, this region is likely to remain a major lucrative market, with an estimated CAGR of 15.9%.

Explore Full Report With Detailed TOC Here:
https://www.marketinsightsreports.com/reports/01141750879/global-polymeric-biomaterials-market-research-report-2020?Mode=31&Source=op

This report segments the global Polymeric Biomaterials Market on the basis of Types are
Nylon, Silicone Rubber, Polyester, Polymethyl Methacrylate (PMMA), Polyethylene (PE), Polyvinyl Chloride, Others

On The basis Of Application, the Global Polymeric Biomaterials Market is segmented into
Cardiovascular, Ophthalmology, Dental, Plastic Surgery, Wound Healing, Tissue Engineering, Orthopedics

Regions Are covered By Polymeric Biomaterials Market Report 2020 To 2026. North America, Europe, China, Japan, Southeast Asia, India, North America (USA, Canada, and Mexico) Europe (Germany, France, UK, Russia, and Italy) Asia-Pacific (China, Japan, Korea, India, and Southeast Asia).

Significant Key Factor Analysis of the Polymeric Biomaterials Market:

o Business overview- An exhaustive description of the company's operations and business divisions
o Corporate strategy - Analyst's summarization of the company's business strategy
o SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities, and threats
o Company history - Progression of key events associated with the company
o Major products and services-A list of major products, services, and brands of the company
o Key competitors - A list of key competitors to the company
o Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company
o Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years of history

Finally, all aspects of the Global Market are quantitatively as well qualitatively assessed to study the Global as well as regional market comparatively. This market study presents critical information and factual data about the market providing an overall statistical study of this market on the basis of market drivers, limitations, and future prospects. The report supplies the international economic competition with the assistance of Porter's Five Forces Analysis and SWOT Analysis.

How we have factored the effect of Covid-19 in our report:
All the reports that we list have been tracking the impact of COVID-19. Both upstream and downstream of the entire supply chain has been accounted for while doing this. Also, where possible, we will provide an additional COVID-19 update supplement/report to the report in Q3, please check for with the sales team.

Contact Us:
Irfan Tamboli (Head of Sales) - Market Insights Reports
Phone: + 1704 266 3234 | +91-750-707-8687
sales@marketinsightsreports.com|irfan@marketinsightsreports.com

About Us:
MarketInsightsReports provides syndicated market research on industry verticals including Healthcare, Information, and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. MarketInsightsReports provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

This release was published on openPR.